Occlutech develops and manufactures cardiac occlusion devices and other vascular implants for structural heart diseases. Its products target conditions such as atrial septal defect (ASD), patent foramen ovale (PFO) and left atrial appendage (LAA). The company is based in Helsingborg, Sweden and was founded in 2003. It is led by CEO Tor Peters. Occlutech intends to use new funding to accelerate R&D and bring new products to market in the near future. The article does not disclose operating metrics or revenue.

Total raised

$22M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2011